In the last 12 months, insiders at BIOGEN INC. ($BIIB) filed 491 transactions with the SEC: 3 open-market purchases totaling $253,400 and 20 sales totaling $7,441,953. Net insider sentiment: net selling.
BIOGEN INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Singhal Priya (Head of Development) — 83 transactions totaling $4,132,739
- Gregory Ginger (EVP, Human Resources) — 50 transactions totaling $3,518,840
- Viehbacher Christopher (President and CEO) — 15 transactions totaling $3,266,581
- MCDONNELL MICHAEL R (EVP, Chief Financial Officer) — 39 transactions totaling $3,093,066
- BIOGEN INC. (TenPercentOwner) — 1 transaction totaling $3,000,000
View all SEC Filings for BIOGEN INC. (BIIB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Godbout Sean | Chief Accounting Officer | M | Common Stock | 181 | $0.00 | 1,395.6667 | 170,500,000 | 14.90% | 0.00% |
| April 1, 2026 | Godbout Sean | Chief Accounting Officer | F | Common Stock | 54 | $183.78 | 1,341.6667 | 170,500,000 | 3.87% | 0.00% |
| April 1, 2026 | Godbout Sean | Chief Accounting Officer | M | Restricted Stock Unit | 181 | $0.00 | 364.0000 | 170,500,000 | 33.21% | 0.00% |
| Feb. 13, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 10560 | $0.00 | 10,560.0000 | 170,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | Kramer Robin | Chief Financial Officer | A | Restricted Stock Unit | 8450 | $0.00 | 8,450.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 8025 | $0.00 | 8,025.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 7390 | $0.00 | 7,390.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 38015 | $0.00 | 38,015.0000 | 170,500,000 | 9999.99% | 0.02% |
| Feb. 13, 2026 | Gregory Ginger | EVP, Human Resources | A | Restricted Stock Unit | 8025 | $0.00 | 8,025.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Godbout Sean | Chief Accounting Officer | A | Restricted Stock Unit | 1800 | $0.00 | 1,800.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | A | Restricted Stock Unit | 8450 | $0.00 | 8,450.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Grogan Jane | Head of Research | A | Restricted Stock Unit | 8450 | $0.00 | 8,450.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | Singhal Priya | Head of Development | A | Restricted Stock Unit | 10560 | $0.00 | 10,560.0000 | 170,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | P | Common Stock | 3 | $195.04 | 19,611.0408 | 170,500,000 | 0.02% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2102 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 1408 | $201.18 | 19,608.0408 | 170,500,000 | 6.70% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 4683 | $0.00 | 21,016.0408 | 170,500,000 | 28.67% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 914 | $201.18 | 16,333.0408 | 170,500,000 | 5.30% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 1940 | $0.00 | 17,247.0408 | 170,500,000 | 12.67% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 1017 | $201.18 | 15,307.0408 | 170,500,000 | 6.23% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2102 | $0.00 | 16,324.0408 | 170,500,000 | 14.78% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 4683 | $0.00 | 9,367.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 2217 | $0.00 | 2,217.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 9, 2026 | Singhal Priya | Head of Development | S | Common Stock | 2660 | $199.83 | 8,043.1428 | 170,500,000 | 24.85% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | F | Common Stock | 1412 | $201.18 | 10,703.1428 | 170,500,000 | 11.65% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | M | Common Stock | 4683 | $0.00 | 12,115.1428 | 170,500,000 | 63.01% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | F | Common Stock | 1056 | $201.18 | 7,432.1428 | 170,500,000 | 12.44% | 0.00% |
| Feb. 6, 2026 | Singhal Priya | Head of Development | M | Common Stock | 2217 | $0.00 | 8,488.1428 | 170,500,000 | 35.35% | 0.00% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 15453 | $0.00 | 30,907.0000 | 170,500,000 | 33.33% | 0.01% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 9008 | $0.00 | 9,009.0000 | 170,500,000 | 50.00% | 0.01% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | F | Common Stock | 6624 | $201.18 | 29,924.0000 | 170,500,000 | 18.12% | 0.00% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | M | Common Stock | 15453 | $0.00 | 36,548.0000 | 170,500,000 | 73.25% | 0.01% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | F | Common Stock | 4356 | $201.18 | 21,095.0000 | 170,500,000 | 17.12% | 0.00% |
| Feb. 6, 2026 | Viehbacher Christopher | President and CEO | M | Common Stock | 9008 | $0.00 | 25,451.0000 | 170,500,000 | 54.78% | 0.01% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | M | Common Stock | 3278 | $0.00 | 6,875.0000 | 170,500,000 | 91.13% | 0.00% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | F | Common Stock | 589 | $201.18 | 3,597.0000 | 170,500,000 | 14.07% | 0.00% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | M | Common Stock | 1802 | $0.00 | 4,186.0000 | 170,500,000 | 75.59% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 3511 | $0.00 | 7,024.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 703 | $0.00 | 704.0000 | 170,500,000 | 49.96% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 789 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | F | Common Stock | 1063 | $201.18 | 11,471.7483 | 170,500,000 | 8.48% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Common Stock | 3511 | $0.00 | 12,534.7483 | 170,500,000 | 38.91% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | F | Common Stock | 207 | $201.18 | 9,023.7483 | 170,500,000 | 2.24% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Common Stock | 703 | $0.00 | 9,230.7483 | 170,500,000 | 8.24% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | F | Common Stock | 273 | $201.18 | 8,527.7483 | 170,500,000 | 3.10% | 0.00% |
| Feb. 6, 2026 | Kramer Robin | Chief Financial Officer | M | Common Stock | 789 | $0.00 | 8,800.7483 | 170,500,000 | 9.85% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 4683 | $0.00 | 9,367.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 1940 | $0.00 | 1,940.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 4916 | $0.00 | 9,834.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 1940 | $0.00 | 1,940.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 2190 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 1514 | $201.18 | 61,889.0000 | 170,500,000 | 2.39% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 4916 | $0.00 | 63,403.0000 | 170,500,000 | 8.41% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 931 | $201.18 | 58,487.0000 | 170,500,000 | 1.57% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 1940 | $0.00 | 59,418.0000 | 170,500,000 | 3.38% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 1059 | $201.18 | 57,478.0000 | 170,500,000 | 1.81% | 0.00% |
| Feb. 6, 2026 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 2190 | $0.00 | 58,537.0000 | 170,500,000 | 3.89% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Restricted Stock Unit | 517 | $0.00 | 1,035.0000 | 170,500,000 | 33.31% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Restricted Stock Unit | 305 | $0.00 | 305.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Restricted Stock Unit | 257 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | F | Common Stock | 180 | $201.18 | 1,214.6667 | 170,500,000 | 12.91% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Common Stock | 517 | $0.00 | 1,394.6667 | 170,500,000 | 58.91% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | F | Common Stock | 103 | $201.18 | 877.6667 | 170,500,000 | 10.50% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Common Stock | 305 | $0.00 | 980.6667 | 170,500,000 | 45.14% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | F | Common Stock | 76 | $201.18 | 675.6667 | 170,500,000 | 10.11% | 0.00% |
| Feb. 6, 2026 | Godbout Sean | Chief Accounting Officer | M | Common Stock | 257 | $0.00 | 751.6667 | 170,500,000 | 51.95% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 3746 | $0.00 | 7,494.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1802 | $0.00 | 1,802.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1635 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 1132 | $201.18 | 22,358.7673 | 170,500,000 | 4.82% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 3746 | $0.00 | 23,490.7673 | 170,500,000 | 18.97% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 666 | $201.18 | 19,744.7673 | 170,500,000 | 3.26% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1802 | $0.00 | 20,410.7673 | 170,500,000 | 9.68% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 791 | $201.18 | 18,608.7673 | 170,500,000 | 4.08% | 0.00% |
| Feb. 6, 2026 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1635 | $0.00 | 19,399.7673 | 170,500,000 | 9.20% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1873 | $0.00 | 3,747.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1385 | $0.00 | 1,385.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | F | Common Stock | 584 | $201.18 | 4,058.0000 | 170,500,000 | 12.58% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | M | Common Stock | 1873 | $0.00 | 4,642.0000 | 170,500,000 | 67.64% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | F | Common Stock | 407 | $201.18 | 2,769.0000 | 170,500,000 | 12.81% | 0.00% |
| Feb. 6, 2026 | Grogan Jane | Head of Research | M | Common Stock | 1385 | $0.00 | 3,176.0000 | 170,500,000 | 77.33% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 3043 | $0.00 | 6,087.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1802 | $0.00 | 1,802.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2044 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 775 | $201.18 | 11,011.0000 | 170,500,000 | 6.58% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 3043 | $0.00 | 11,786.0000 | 170,500,000 | 34.80% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 458 | $201.18 | 8,743.0000 | 170,500,000 | 4.98% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1802 | $0.00 | 9,201.0000 | 170,500,000 | 24.35% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 805 | $201.18 | 7,399.0000 | 170,500,000 | 9.81% | 0.00% |
| Feb. 6, 2026 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2044 | $0.00 | 8,204.0000 | 170,500,000 | 33.18% | 0.00% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 3278 | $0.00 | 6,557.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 1802 | $0.00 | 1,802.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | Keeney Adam | Head of Corporate Development | F | Common Stock | 994 | $201.18 | 5,881.0000 | 170,500,000 | 14.46% | 0.00% |
| Jan. 30, 2026 | Singhal Priya | Head of Development | M | Common Stock | 1829 | $0.00 | 7,601.1428 | 170,500,000 | 31.69% | 0.00% |
| Jan. 30, 2026 | Singhal Priya | Head of Development | F | Common Stock | 582 | $179.89 | 7,019.1428 | 170,500,000 | 7.66% | 0.00% |
| Feb. 2, 2026 | Singhal Priya | Head of Development | S | Common Stock | 748 | $179.30 | 6,271.1428 | 170,500,000 | 10.66% | 0.00% |
| Jan. 30, 2026 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1829 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | Viehbacher Christopher | President and CEO | M | Common Stock | 7040 | $0.00 | 19,847.0000 | 170,500,000 | 54.97% | 0.00% |
| Dec. 1, 2025 | Viehbacher Christopher | President and CEO | F | Common Stock | 3404 | $177.78 | 16,443.0000 | 170,500,000 | 17.15% | 0.00% |
| Dec. 1, 2025 | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 7040 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Oct. 31, 2025 | Grogan Jane | Head of Research | M | Common Stock | 695 | $0.00 | 2,128.0000 | 170,500,000 | 48.50% | 0.00% |
| Oct. 31, 2025 | Grogan Jane | Head of Research | F | Common Stock | 337 | $154.27 | 1,791.0000 | 170,500,000 | 15.84% | 0.00% |
| Oct. 31, 2025 | Grogan Jane | Head of Research | M | Restricted Stock Unit | 695 | $0.00 | 695.0000 | 170,500,000 | 50.00% | 0.00% |
| Oct. 2, 2025 | Godbout Sean | Chief Accounting Officer | M | Common Stock | 26 | $0.00 | 502.6667 | 170,500,000 | 5.45% | 0.00% |
| Oct. 2, 2025 | Godbout Sean | Chief Accounting Officer | M | Restricted Stock Unit | 26 | $0.00 | 27.0000 | 170,500,000 | 49.06% | 0.00% |
| Oct. 2, 2025 | Godbout Sean | Chief Accounting Officer | F | Common Stock | 8 | $155.25 | 494.6667 | 170,500,000 | 1.59% | 0.00% |
| Sept. 2, 2025 | Singhal Priya | Head of Development | S | Common Stock | 517 | $133.55 | 5,772.1428 | 170,400,000 | 8.22% | 0.00% |
| Aug. 29, 2025 | Singhal Priya | Head of Development | M | Common Stock | 1669 | $0.00 | 7,096.1428 | 170,400,000 | 30.75% | 0.00% |
| Aug. 29, 2025 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1669 | $0.00 | 0.0000 | 170,400,000 | 100.00% | 0.00% |
| Aug. 29, 2025 | Singhal Priya | Head of Development | F | Common Stock | 807 | $132.22 | 6,289.1428 | 170,400,000 | 11.37% | 0.00% |
| July 8, 2025 | Izzar Rachid | Head of Global Product Strat. | S | Common Stock | 2223 | $135.00 | 6,330.0000 | 170,400,000 | 25.99% | 0.00% |
| June 17, 2025 | Minor Lloyd | Director | A | Common Stock | 2370 | $0.00 | 2,370.0000 | 169,500,000 | 9999.99% | 0.00% |
| June 17, 2025 | HAWKINS WILLIAM A | Director | A | Common Stock | 2370 | $0.00 | 8,860.0000 | 169,500,000 | 36.52% | 0.00% |
| June 17, 2025 | Freire Maria C | Director | A | Common Stock | 2370 | $0.00 | 6,815.0000 | 169,500,000 | 53.32% | 0.00% |
| June 17, 2025 | Rowinsky Eric K | Director | A | Common Stock | 2370 | $0.00 | 24,339.0000 | 169,500,000 | 10.79% | 0.00% |
| June 17, 2025 | SHERWIN STEPHEN A | Director | A | Common Stock | 2370 | $0.00 | 13,688.0000 | 169,500,000 | 20.94% | 0.00% |
| June 17, 2025 | LANGER SUSAN | Director | A | Common Stock | 2370 | $0.00 | 5,129.1000 | 169,500,000 | 85.90% | 0.00% |
| June 17, 2025 | DORSA CAROLINE | Director | A | Common Stock | 3160 | $0.00 | 31,002.0000 | 169,500,000 | 11.35% | 0.00% |
| June 17, 2025 | Mantas Jesus B | Director | A | Common Stock | 2370 | $0.00 | 9,758.0000 | 169,500,000 | 32.08% | 0.00% |
| June 17, 2025 | Patolawala Monish D | Director | A | Common Stock | 2370 | $0.00 | 3,710.0000 | 169,500,000 | 176.87% | 0.00% |
| June 17, 2025 | Pangalos Menelas N | Director | A | Restricted Stock Unit | 2370 | $0.00 | 2,370.0000 | 169,500,000 | 9999.99% | 0.00% |
| May 19, 2025 | Singhal Priya | Head of Development | S | Common Stock | 3806 | $126.25 | 5,427.1428 | 169,500,000 | 41.22% | 0.00% |
| May 2, 2025 | DORSA CAROLINE | Director | P | Common Stock | 1235 | $122.72 | 27,842.0000 | 169,500,000 | 4.64% | 0.00% |
| May 1, 2025 | Keeney Adam | Head of Corporate Development | M | Common Stock | 938 | $0.00 | 2,838.0000 | 169,500,000 | 49.37% | 0.00% |
| May 1, 2025 | Keeney Adam | Head of Corporate Development | F | Common Stock | 454 | $120.93 | 2,384.0000 | 169,500,000 | 16.00% | 0.00% |
| May 1, 2025 | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 938 | $0.00 | 939.0000 | 169,500,000 | 49.97% | 0.00% |
| April 1, 2025 | Godbout Sean | Chief Accounting Officer | A | Restricted Stock Unit | 545 | $0.00 | 545.0000 | 169,500,000 | 9999.99% | 0.00% |
| March 7, 2025 | SHERWIN STEPHEN A | Director | S | Common Stock | 8760 | $150.02 | 11,318.0000 | 169,500,000 | 43.63% | 0.01% |
| Feb. 10, 2025 | Singhal Priya | Head of Development | M | Common Stock | 1212 | $0.00 | 9,423.4761 | 169,500,000 | 14.76% | 0.00% |
| Feb. 10, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 670 | $142.54 | 14,055.3741 | 169,500,000 | 4.55% | 0.00% |
| Feb. 10, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2272 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 3257 | $0.00 | 25,712.0000 | 169,500,000 | 14.50% | 0.00% |
| Feb. 10, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1371 | $142.54 | 24,341.0000 | 169,500,000 | 5.33% | 0.00% |
| Feb. 10, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 3257 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 834 | $0.00 | 8,256.7483 | 169,500,000 | 11.24% | 0.00% |
| Feb. 10, 2025 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 245 | $142.54 | 8,011.7483 | 169,500,000 | 2.97% | 0.00% |
| Feb. 10, 2025 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 834 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 2159 | $0.00 | 18,232.1006 | 169,500,000 | 13.43% | 0.00% |
| Feb. 10, 2025 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 634 | $142.54 | 17,598.1006 | 169,500,000 | 3.48% | 0.00% |
| Feb. 10, 2025 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 2159 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 2575 | $0.00 | 57,154.0000 | 169,500,000 | 4.72% | 0.00% |
| Feb. 10, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 807 | $142.54 | 56,347.0000 | 169,500,000 | 1.41% | 0.00% |
| Feb. 10, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 2575 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 8,998.0000 | 169,500,000 | 20.25% | 0.00% |
| Feb. 10, 2025 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 445 | $142.54 | 8,553.0000 | 169,500,000 | 4.95% | 0.00% |
| Feb. 10, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1212 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | Singhal Priya | Head of Development | F | Common Stock | 357 | $142.54 | 9,066.4761 | 169,500,000 | 3.79% | 0.00% |
| Feb. 10, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2272 | $0.00 | 14,725.3741 | 169,500,000 | 18.24% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1801 | $0.00 | 7,860.0000 | 169,500,000 | 29.72% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2043 | $0.00 | 2,044.0000 | 169,500,000 | 49.99% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1801 | $0.00 | 3,604.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2043 | $0.00 | 7,224.0000 | 169,500,000 | 39.43% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 600 | $141.35 | 6,624.0000 | 169,500,000 | 8.31% | 0.00% |
| Feb. 7, 2025 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 565 | $141.35 | 6,059.0000 | 169,500,000 | 8.53% | 0.00% |
| Feb. 6, 2025 | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 9835 | $0.00 | 9,835.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2335 | $0.00 | 21,741.0000 | 169,500,000 | 12.03% | 0.00% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 786 | $141.35 | 20,955.0000 | 169,500,000 | 3.62% | 0.00% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2216 | $0.00 | 23,171.0000 | 169,500,000 | 10.58% | 0.00% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 716 | $141.35 | 22,455.0000 | 169,500,000 | 3.09% | 0.00% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2335 | $0.00 | 2,335.0000 | 169,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2216 | $0.00 | 4,434.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | Viehbacher Christopher | President and CEO | M | Common Stock | 9008 | $0.00 | 16,008.0000 | 169,500,000 | 128.69% | 0.01% |
| Feb. 7, 2025 | Viehbacher Christopher | President and CEO | F | Common Stock | 3201 | $141.35 | 12,807.0000 | 169,500,000 | 20.00% | 0.00% |
| Feb. 6, 2025 | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 46360 | $0.00 | 46,360.0000 | 169,500,000 | 9999.99% | 0.03% |
| Feb. 7, 2025 | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 9008 | $0.00 | 18,017.0000 | 169,500,000 | 33.33% | 0.01% |
| Feb. 7, 2025 | Grogan Jane | Head of Research | M | Common Stock | 1385 | $0.00 | 1,876.0000 | 169,500,000 | 282.08% | 0.00% |
| Feb. 7, 2025 | Grogan Jane | Head of Research | F | Common Stock | 443 | $141.35 | 1,433.0000 | 169,500,000 | 23.61% | 0.00% |
| Feb. 6, 2025 | Grogan Jane | Head of Research | A | Restricted Stock Unit | 5620 | $0.00 | 5,620.0000 | 169,500,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | Grogan Jane | Head of Research | M | Restricted Stock Unit | 1385 | $0.00 | 2,770.0000 | 169,500,000 | 33.33% | 0.00% |
| Feb. 7, 2025 | Keeney Adam | Head of Corporate Development | M | Common Stock | 1801 | $0.00 | 2,463.0000 | 169,500,000 | 272.05% | 0.00% |
| Feb. 7, 2025 | Keeney Adam | Head of Corporate Development | F | Common Stock | 563 | $141.35 | 1,900.0000 | 169,500,000 | 22.86% | 0.00% |
| Feb. 7, 2025 | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 1801 | $0.00 | 3,604.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 6, 2025 | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 9130 | $0.00 | 9,130.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 788 | $0.00 | 7,195.7483 | 169,500,000 | 12.30% | 0.00% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 232 | $141.35 | 6,963.7483 | 169,500,000 | 3.22% | 0.00% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 703 | $0.00 | 7,666.7483 | 169,500,000 | 10.10% | 0.00% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 244 | $141.35 | 7,422.7483 | 169,500,000 | 3.18% | 0.00% |
| Feb. 6, 2025 | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 10535 | $0.00 | 10,535.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 788 | $0.00 | 789.0000 | 169,500,000 | 49.97% | 0.00% |
| Feb. 7, 2025 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 703 | $0.00 | 1,407.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2102 | $0.00 | 11,736.3741 | 169,500,000 | 21.82% | 0.00% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 620 | $141.35 | 11,116.3741 | 169,500,000 | 5.28% | 0.00% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 1940 | $0.00 | 13,056.3741 | 169,500,000 | 17.45% | 0.00% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 603 | $141.35 | 12,453.3741 | 169,500,000 | 4.62% | 0.00% |
| Feb. 6, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 14050 | $0.00 | 14,050.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2102 | $0.00 | 2,102.0000 | 169,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 1940 | $0.00 | 3,880.0000 | 169,500,000 | 33.33% | 0.00% |
| Feb. 7, 2025 | Singhal Priya | Head of Development | M | Common Stock | 2216 | $0.00 | 8,892.4761 | 169,500,000 | 33.19% | 0.00% |
| Feb. 7, 2025 | Singhal Priya | Head of Development | F | Common Stock | 681 | $141.35 | 8,211.4761 | 169,500,000 | 7.66% | 0.00% |
| Feb. 6, 2025 | Singhal Priya | Head of Development | A | Restricted Stock Unit | 14050 | $0.00 | 14,050.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 2216 | $0.00 | 4,434.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1635 | $0.00 | 15,312.1006 | 169,500,000 | 11.95% | 0.00% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 480 | $141.35 | 14,832.1006 | 169,500,000 | 3.13% | 0.00% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1801 | $0.00 | 16,633.1006 | 169,500,000 | 12.14% | 0.00% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 560 | $141.35 | 16,073.1006 | 169,500,000 | 3.37% | 0.00% |
| Feb. 6, 2025 | Gregory Ginger | EVP, Human Resources | A | Restricted Stock Unit | 11240 | $0.00 | 11,240.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1635 | $0.00 | 1,635.0000 | 169,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1801 | $0.00 | 3,604.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 2190 | $0.00 | 53,873.0000 | 169,500,000 | 4.24% | 0.00% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 643 | $141.35 | 53,230.0000 | 169,500,000 | 1.19% | 0.00% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 1940 | $0.00 | 55,170.0000 | 169,500,000 | 3.64% | 0.00% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 591 | $141.35 | 54,579.0000 | 169,500,000 | 1.07% | 0.00% |
| Feb. 6, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | A | Restricted Stock Unit | 14750 | $0.00 | 14,750.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 2190 | $0.00 | 2,190.0000 | 169,500,000 | 50.00% | 0.00% |
| Feb. 7, 2025 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 1940 | $0.00 | 3,880.0000 | 169,500,000 | 33.33% | 0.00% |
| Jan. 31, 2025 | Singhal Priya | Head of Development | M | Common Stock | 1828 | $0.00 | 7,254.4761 | 169,500,000 | 33.69% | 0.00% |
| Jan. 31, 2025 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1828 | $0.00 | 1,829.0000 | 169,500,000 | 49.99% | 0.00% |
| Jan. 31, 2025 | Singhal Priya | Head of Development | F | Common Stock | 578 | $143.93 | 6,676.4761 | 169,500,000 | 7.97% | 0.00% |
| Dec. 9, 2024 | Singhal Priya | Head of Development | S | Common Stock | 110 | $157.21 | 5,426.4761 | 169,500,000 | 1.99% | 0.00% |
| Dec. 6, 2024 | Singhal Priya | Head of Development | F | Common Stock | 206 | $157.78 | 5,536.4761 | 169,500,000 | 3.59% | 0.00% |
| Dec. 6, 2024 | Singhal Priya | Head of Development | M | Common Stock | 426 | $0.00 | 5,742.4761 | 169,500,000 | 8.01% | 0.00% |
| Dec. 6, 2024 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 351 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Dec. 6, 2024 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 170 | $157.78 | 6,407.7483 | 169,500,000 | 2.58% | 0.00% |
| Dec. 6, 2024 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 351 | $0.00 | 6,577.7483 | 169,500,000 | 5.64% | 0.00% |
| Dec. 6, 2024 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 426 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Nov. 5, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | G | Common Stock | 20082 | $0.00 | 51,683.0000 | 169,500,000 | 63.55% | 0.01% |
| Nov. 5, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | G | Common Stock | 20082 | $0.00 | 51,683.0000 | 169,500,000 | 27.98% | 0.01% |
| Nov. 1, 2024 | Grogan Jane | Head of Research | M | Restricted Stock Unit | 695 | $0.00 | 1,390.0000 | 169,500,000 | 33.33% | 0.00% |
| Nov. 1, 2024 | Grogan Jane | Head of Research | F | Common Stock | 204 | $173.79 | 491.0000 | 169,500,000 | 29.35% | 0.00% |
| Nov. 1, 2024 | Grogan Jane | Head of Research | M | Common Stock | 695 | $0.00 | 695.0000 | 169,500,000 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Singhal Priya | Head of Development | S | Common Stock | 431 | $204.22 | 5,316.4761 | 169,500,000 | 7.50% | 0.00% |
| Aug. 30, 2024 | Singhal Priya | Head of Development | M | Common Stock | 1668 | $0.00 | 6,554.4761 | 169,500,000 | 34.14% | 0.00% |
| Aug. 30, 2024 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1668 | $0.00 | 1,669.0000 | 169,500,000 | 49.99% | 0.00% |
| Aug. 30, 2024 | Singhal Priya | Head of Development | F | Common Stock | 807 | $204.76 | 5,747.4761 | 169,500,000 | 12.31% | 0.00% |
| June 21, 2024 | DORSA CAROLINE | Director | A | Common Stock | 1785 | $0.00 | 26,607.0000 | 168,700,000 | 7.19% | 0.00% |
| June 21, 2024 | HAWKINS WILLIAM A | Director | A | Common Stock | 1340 | $0.00 | 6,490.0000 | 168,700,000 | 26.02% | 0.00% |
| June 21, 2024 | Patolawala Monish D | Director | A | Common Stock | 1340 | $0.00 | 1,340.0000 | 168,700,000 | 9999.99% | 0.00% |
| June 21, 2024 | LANGER SUSAN | Director | A | Common Stock | 1340 | $0.00 | 2,759.1000 | 168,700,000 | 94.43% | 0.00% |
| June 21, 2024 | Rowinsky Eric K | Director | A | Common Stock | 1340 | $0.00 | 21,969.0000 | 168,700,000 | 6.50% | 0.00% |
| June 21, 2024 | Mantas Jesus B | Director | A | Common Stock | 1340 | $0.00 | 7,388.0000 | 168,700,000 | 22.16% | 0.00% |
| June 21, 2024 | SHERWIN STEPHEN A | Director | A | Common Stock | 1340 | $0.00 | 20,078.0000 | 168,700,000 | 7.15% | 0.00% |
| June 21, 2024 | Freire Maria C | Director | A | Common Stock | 1340 | $0.00 | 4,445.0000 | 168,700,000 | 43.16% | 0.00% |
| May 1, 2024 | Keeney Adam | Head of Corporate Development | F | Common Stock | 276 | $216.13 | 662.0000 | 168,700,000 | 29.42% | 0.00% |
| May 1, 2024 | Keeney Adam | Head of Corporate Development | M | Common Stock | 938 | $0.00 | 938.0000 | 168,700,000 | 9999.99% | 0.00% |
| May 1, 2024 | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 938 | $0.00 | 1,877.0000 | 168,700,000 | 33.32% | 0.00% |
| April 1, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 240 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| April 1, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 240 | $0.00 | 9,751.3741 | 168,700,000 | 2.52% | 0.00% |
| April 2, 2024 | Singhal Priya | Head of Development | S | Common Stock | 93 | $213.09 | 4,886.4761 | 168,700,000 | 1.87% | 0.00% |
| April 1, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 117 | $214.83 | 9,634.3741 | 168,700,000 | 1.20% | 0.00% |
| Feb. 22, 2024 | Singhal Priya | Head of Development | S | Common Stock | 262 | $221.23 | 4,886.0915 | 168,700,000 | 5.09% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 431 | $0.00 | 6,353.7483 | 168,700,000 | 7.28% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 3423 | $0.00 | 52,506.0000 | 168,700,000 | 6.97% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 1656 | $219.08 | 50,850.0000 | 168,700,000 | 3.15% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 1614 | $0.00 | 52,464.0000 | 168,700,000 | 3.17% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 781 | $219.08 | 51,683.0000 | 168,700,000 | 1.49% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Performance Stock Unit | 3423 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 1614 | $0.00 | 2,012.0000 | 168,700,000 | 44.51% | 0.00% |
| Feb. 16, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | J | Restricted Stock Unit | 2012 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 3197 | $0.00 | 14,340.7160 | 168,700,000 | 28.69% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 1535 | $219.08 | 12,805.7160 | 168,700,000 | 10.70% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1507 | $0.00 | 14,312.7160 | 168,700,000 | 11.77% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 729 | $219.08 | 13,583.7160 | 168,700,000 | 5.09% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | M | Performance Stock Unit | 3197 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1507 | $0.00 | 1,879.0000 | 168,700,000 | 44.51% | 0.00% |
| Feb. 16, 2024 | Gregory Ginger | EVP, Human Resources | J | Restricted Stock Unit | 1879 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1370 | $0.00 | 10,006.0000 | 168,700,000 | 15.86% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 639 | $219.08 | 9,367.0000 | 168,700,000 | 6.39% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 647 | $0.00 | 10,014.0000 | 168,700,000 | 6.91% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 313 | $219.08 | 9,701.0000 | 168,700,000 | 3.13% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Performance Stock Unit | 1370 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 647 | $0.00 | 807.0000 | 168,700,000 | 44.50% | 0.00% |
| Feb. 16, 2024 | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 807 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 914 | $0.00 | 6,191.7483 | 168,700,000 | 17.32% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 269 | $219.08 | 5,922.7483 | 168,700,000 | 4.34% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 127 | $219.08 | 6,226.7483 | 168,700,000 | 2.00% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | M | Performance Stock Unit | 914 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 431 | $0.00 | 537.0000 | 168,700,000 | 44.52% | 0.00% |
| Feb. 16, 2024 | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 537 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 4568 | $0.00 | 20,692.0000 | 168,700,000 | 28.33% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 2337 | $219.08 | 18,355.0000 | 168,700,000 | 11.29% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2152 | $0.00 | 20,507.0000 | 168,700,000 | 11.72% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1101 | $219.08 | 19,406.0000 | 168,700,000 | 5.37% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Performance Stock Unit | 4568 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2152 | $0.00 | 2,684.0000 | 168,700,000 | 44.50% | 0.00% |
| Feb. 16, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | J | Restricted Stock Unit | 2684 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 856 | $0.00 | 9,623.9895 | 168,700,000 | 9.76% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 414 | $219.08 | 9,209.9895 | 168,700,000 | 4.30% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 404 | $0.00 | 9,613.9895 | 168,700,000 | 4.39% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 196 | $219.08 | 9,417.9895 | 168,700,000 | 2.04% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Performance Stock Unit | 856 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 404 | $0.00 | 504.0000 | 168,700,000 | 44.49% | 0.00% |
| Feb. 16, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 504 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | M | Common Stock | 819 | $0.00 | 5,335.0915 | 168,700,000 | 18.14% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | F | Common Stock | 295 | $219.08 | 5,040.0915 | 168,700,000 | 5.53% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | M | Common Stock | 389 | $0.00 | 5,429.0915 | 168,700,000 | 7.72% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | F | Common Stock | 173 | $219.08 | 5,256.0915 | 168,700,000 | 3.19% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | S | Common Stock | 108 | $221.49 | 5,148.0915 | 168,700,000 | 2.05% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | M | Performance Stock Unit | 819 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 389 | $0.00 | 485.0000 | 168,700,000 | 44.51% | 0.00% |
| Feb. 16, 2024 | Singhal Priya | Head of Development | J | Restricted Stock Unit | 485 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 15, 2024 | Rowinsky Eric K | Director | P | Common Stock | 455 | $222.54 | 20,629.0000 | 168,700,000 | 2.26% | 0.00% |
| Feb. 9, 2024 | Singhal Priya | Head of Development | F | Common Stock | 374 | $240.98 | 4,935.0915 | 168,700,000 | 7.04% | 0.00% |
| Feb. 9, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2272 | $0.00 | 9,528.9895 | 168,700,000 | 31.31% | 0.00% |
| Feb. 12, 2024 | Singhal Priya | Head of Development | S | Common Stock | 419 | $239.45 | 4,516.0915 | 168,700,000 | 8.49% | 0.00% |
| Feb. 9, 2024 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1212 | $0.00 | 1,212.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | Singhal Priya | Head of Development | M | Common Stock | 1212 | $0.00 | 5,309.0915 | 168,700,000 | 29.58% | 0.00% |
| Feb. 9, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 2575 | $0.00 | 2,575.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 938 | $240.98 | 49,083.0000 | 168,700,000 | 1.88% | 0.00% |
| Feb. 9, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 2575 | $0.00 | 50,021.0000 | 168,700,000 | 5.43% | 0.00% |
| Feb. 9, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 1,515.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 445 | $240.98 | 8,636.0000 | 168,700,000 | 4.90% | 0.00% |
| Feb. 9, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 9,081.0000 | 168,700,000 | 20.02% | 0.00% |
| Feb. 9, 2024 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 833 | $0.00 | 834.0000 | 168,700,000 | 49.97% | 0.00% |
| Feb. 9, 2024 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 245 | $240.98 | 5,277.7483 | 168,700,000 | 4.44% | 0.00% |
| Feb. 9, 2024 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 833 | $0.00 | 5,522.7483 | 168,700,000 | 17.76% | 0.00% |
| Feb. 9, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 3257 | $0.00 | 3,257.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1431 | $240.98 | 16,124.0000 | 168,700,000 | 8.15% | 0.00% |
| Feb. 9, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 3257 | $0.00 | 17,555.0000 | 168,700,000 | 22.78% | 0.00% |
| Feb. 9, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2272 | $0.00 | 2,272.0000 | 168,700,000 | 50.00% | 0.00% |
| Feb. 9, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 761 | $240.98 | 8,767.9895 | 168,700,000 | 7.99% | 0.00% |
| Feb. 9, 2024 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 2158 | $0.00 | 11,777.7160 | 168,700,000 | 22.43% | 0.00% |
| Feb. 9, 2024 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 634 | $240.98 | 11,143.7160 | 168,700,000 | 5.38% | 0.00% |
| Feb. 9, 2024 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 2158 | $0.00 | 2,159.0000 | 168,700,000 | 49.99% | 0.00% |
| Feb. 8, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Restricted Stock Unit | 2190 | $0.00 | 4,380.0000 | 168,700,000 | 33.33% | 0.00% |
| Feb. 8, 2024 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1635 | $0.00 | 3,270.0000 | 168,700,000 | 33.33% | 0.00% |
| Feb. 7, 2024 | Gregory Ginger | EVP, Human Resources | A | Restricted Stock Unit | 5405 | $0.00 | 5,405.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 498 | $240.30 | 9,619.7160 | 168,700,000 | 4.92% | 0.00% |
| Feb. 8, 2024 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1635 | $0.00 | 10,117.7160 | 168,700,000 | 19.27% | 0.00% |
| Feb. 7, 2024 | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 27025 | $0.00 | 27,025.0000 | 168,700,000 | 9999.99% | 0.02% |
| Feb. 7, 2024 | Singhal Priya | Head of Development | A | Restricted Stock Unit | 6650 | $0.00 | 6,650.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2101 | $0.00 | 4,204.0000 | 168,700,000 | 33.32% | 0.00% |
| Feb. 7, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 5820 | $0.00 | 5,820.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 638 | $240.30 | 7,256.9895 | 168,700,000 | 8.08% | 0.00% |
| Feb. 8, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2101 | $0.00 | 7,894.9895 | 168,700,000 | 36.26% | 0.00% |
| Feb. 8, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2335 | $0.00 | 4,670.0000 | 168,700,000 | 33.33% | 0.00% |
| Feb. 7, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | A | Restricted Stock Unit | 6650 | $0.00 | 6,650.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 765 | $240.30 | 14,298.0000 | 168,700,000 | 5.08% | 0.00% |
| Feb. 8, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2335 | $0.00 | 15,063.0000 | 168,700,000 | 18.35% | 0.00% |
| Feb. 8, 2024 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 788 | $0.00 | 1,577.0000 | 168,700,000 | 33.32% | 0.00% |
| Feb. 7, 2024 | Grogan Jane | Head of Research | A | Restricted Stock Unit | 4155 | $0.00 | 4,155.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | F | Common Stock | 655 | $240.30 | 47,446.0000 | 168,700,000 | 1.36% | 0.00% |
| Feb. 8, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | M | Common Stock | 2190 | $0.00 | 48,101.0000 | 168,700,000 | 4.77% | 0.00% |
| Feb. 7, 2024 | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 2110 | $0.00 | 2,110.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 253 | $240.30 | 4,689.7483 | 168,700,000 | 5.12% | 0.00% |
| Feb. 8, 2024 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 788 | $0.00 | 4,942.7483 | 168,700,000 | 18.97% | 0.00% |
| Feb. 7, 2024 | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 5405 | $0.00 | 5,405.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 2043 | $0.00 | 4,087.0000 | 168,700,000 | 33.33% | 0.00% |
| Feb. 7, 2024 | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 5405 | $0.00 | 5,405.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 8, 2024 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 621 | $240.30 | 7,566.0000 | 168,700,000 | 7.59% | 0.00% |
| Feb. 8, 2024 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 2043 | $0.00 | 8,187.0000 | 168,700,000 | 33.25% | 0.00% |
| Feb. 7, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | A | Restricted Stock Unit | 5820 | $0.00 | 5,820.0000 | 168,700,000 | 9999.99% | 0.00% |
| Feb. 2, 2024 | Singhal Priya | Head of Development | S | Common Stock | 634 | $245.93 | 4,097.0915 | 168,700,000 | 13.40% | 0.00% |
| Feb. 1, 2024 | Singhal Priya | Head of Development | F | Common Stock | 561 | $247.83 | 4,731.0915 | 168,700,000 | 10.60% | 0.00% |
| Feb. 1, 2024 | Singhal Priya | Head of Development | M | Common Stock | 1828 | $0.00 | 5,292.0915 | 168,700,000 | 52.77% | 0.00% |
| Feb. 1, 2024 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1828 | $0.00 | 3,657.0000 | 168,700,000 | 33.33% | 0.00% |
| Jan. 29, 2024 | Gregory Ginger | EVP, Human Resources | A | Performance Stock Unit | 3197 | $0.00 | 3,197.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Singhal Priya | Head of Development | A | Performance Stock Unit | 819 | $0.00 | 819.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Murphy Nicole | Head of Pharm Ops and Tech | A | Performance Stock Unit | 856 | $0.00 | 856.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | A | Performance Stock Unit | 4568 | $0.00 | 4,568.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Kramer Robin | Chief Accounting Officer | A | Performance Stock Unit | 914 | $0.00 | 914.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Izzar Rachid | Head of Global Product Strat. | A | Performance Stock Unit | 1370 | $0.00 | 1,370.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | ALEXANDER SUSAN H | EVP Chief Legal Officer | A | Performance Stock Unit | 3423 | $0.00 | 3,423.0000 | 168,700,000 | 9999.99% | 0.00% |
| Dec. 8, 2023 | Singhal Priya | Head of Development | M | Common Stock | 426 | $0.00 | 3,780.0915 | 167,900,000 | 12.70% | 0.00% |
| Dec. 11, 2023 | Singhal Priya | Head of Development | S | Common Stock | 110 | $248.00 | 3,464.0915 | 167,900,000 | 3.08% | 0.00% |
| Dec. 8, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 426 | $0.00 | 426.0000 | 167,900,000 | 50.00% | 0.00% |
| Dec. 8, 2023 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 351 | $0.00 | 4,324.7483 | 167,900,000 | 8.83% | 0.00% |
| Dec. 8, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 170 | $239.29 | 4,154.7483 | 167,900,000 | 3.93% | 0.00% |
| Dec. 8, 2023 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 351 | $0.00 | 351.0000 | 167,900,000 | 50.00% | 0.00% |
| Dec. 8, 2023 | Singhal Priya | Head of Development | F | Common Stock | 206 | $239.29 | 3,574.0915 | 167,900,000 | 5.45% | 0.00% |
| Nov. 1, 2023 | Grogan Jane | Head of Research | A | Restricted Stock Unit | 2085 | $0.00 | 2,085.0000 | 167,900,000 | 9999.99% | 0.00% |
| Sept. 26, 2023 | BIOGEN INC. | TenPercentOwner | S | Common Stock | 6000000 | $0.50 | 17,652,466.0000 | 167,900,000 | 25.37% | 3.57% |
| Sept. 1, 2023 | Singhal Priya | Head of Development | F | Common Stock | 807 | $267.17 | 3,785.0915 | 167,900,000 | 17.57% | 0.00% |
| Sept. 1, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1668 | $0.00 | 3,337.0000 | 167,900,000 | 33.33% | 0.00% |
| Sept. 5, 2023 | Singhal Priya | Head of Development | S | Common Stock | 431 | $269.43 | 3,354.0915 | 167,900,000 | 11.39% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2682 | $0.00 | 12,829.0000 | 167,900,000 | 26.43% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1372 | $267.17 | 11,457.0000 | 167,900,000 | 10.69% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2603 | $0.00 | 14,060.0000 | 167,900,000 | 22.72% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1332 | $267.17 | 12,728.0000 | 167,900,000 | 9.47% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2682 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2603 | $0.00 | 2,763.0000 | 167,900,000 | 48.51% | 0.00% |
| Sept. 1, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | J | Restricted Stock Unit | 2763 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | Singhal Priya | Head of Development | M | Common Stock | 1668 | $0.00 | 4,592.0915 | 167,900,000 | 57.04% | 0.00% |
| June 30, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 315 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| June 30, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 504 | $0.00 | 6,388.0000 | 167,900,000 | 8.57% | 0.00% |
| June 30, 2023 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 244 | $284.85 | 6,144.0000 | 167,900,000 | 3.82% | 0.00% |
| June 30, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 504 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| June 30, 2023 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 252 | $0.00 | 4,095.7483 | 167,900,000 | 6.56% | 0.00% |
| June 30, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 122 | $284.85 | 3,973.7483 | 167,900,000 | 2.98% | 0.00% |
| June 30, 2023 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 252 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| June 30, 2023 | Singhal Priya | Head of Development | M | Common Stock | 315 | $0.00 | 3,158.0915 | 167,900,000 | 11.08% | 0.00% |
| June 30, 2023 | Singhal Priya | Head of Development | F | Common Stock | 153 | $284.85 | 3,005.0915 | 167,900,000 | 4.84% | 0.00% |
| July 3, 2023 | Singhal Priya | Head of Development | S | Common Stock | 81 | $282.87 | 2,924.0915 | 167,900,000 | 2.70% | 0.00% |
| June 26, 2023 | DORSA CAROLINE | Director | A | Common Stock | 1580 | $0.00 | 24,822.0000 | 167,900,000 | 6.80% | 0.00% |
| June 26, 2023 | SHERWIN STEPHEN A | Director | A | Common Stock | 960 | $0.00 | 18,738.0000 | 167,900,000 | 5.40% | 0.00% |
| June 26, 2023 | Rowinsky Eric K | Director | A | Common Stock | 960 | $0.00 | 20,174.0000 | 167,900,000 | 5.00% | 0.00% |
| June 26, 2023 | Mantas Jesus B | Director | A | Common Stock | 960 | $0.00 | 6,048.0000 | 167,900,000 | 18.87% | 0.00% |
| June 26, 2023 | LANGER SUSAN | Director | A | Common Stock | 960 | $0.00 | 1,419.1000 | 167,900,000 | 209.10% | 0.00% |
| June 26, 2023 | HAWKINS WILLIAM A | Director | A | Common Stock | 960 | $0.00 | 5,150.0000 | 167,900,000 | 22.91% | 0.00% |
| June 26, 2023 | Freire Maria C | Director | A | Common Stock | 960 | $0.00 | 3,105.0000 | 167,900,000 | 44.76% | 0.00% |
| April 28, 2023 | Gregory Ginger | EVP, Human Resources | S | Common Stock | 2681 | $300.00 | 8,482.7160 | 167,900,000 | 24.02% | 0.00% |
| May 1, 2023 | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 2815 | $0.00 | 2,815.0000 | 167,900,000 | 9999.99% | 0.00% |
| April 4, 2023 | Singhal Priya | Head of Development | S | Common Stock | 91 | $277.11 | 2,843.0915 | 167,900,000 | 3.10% | 0.00% |
| March 31, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 239 | $0.00 | 240.0000 | 167,900,000 | 49.90% | 0.00% |
| March 31, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 239 | $0.00 | 5,818.2903 | 167,900,000 | 4.28% | 0.00% |
| March 31, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 116 | $278.03 | 5,702.2903 | 167,900,000 | 1.99% | 0.00% |
| March 28, 2023 | Singhal Priya | Head of Development | S | Common Stock | 568 | $270.06 | 2,842.3923 | 167,900,000 | 16.65% | 0.00% |
| March 2, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 297 | $0.00 | 341.0000 | 167,900,000 | 46.55% | 0.00% |
| March 2, 2023 | Singhal Priya | Head of Development | F | Common Stock | 543 | $268.75 | 3,257.3923 | 167,900,000 | 14.29% | 0.00% |
| March 2, 2023 | Singhal Priya | Head of Development | M | Common Stock | 297 | $0.00 | 3,554.3923 | 167,900,000 | 9.12% | 0.00% |
| March 2, 2023 | Singhal Priya | Head of Development | F | Common Stock | 144 | $268.75 | 3,410.3923 | 167,900,000 | 4.05% | 0.00% |
| March 2, 2023 | Singhal Priya | Head of Development | J | Restricted Stock Unit | 341 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 17, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 460 | $0.00 | 1,282.0000 | 167,900,000 | 26.41% | 0.00% |
| Feb. 17, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | J | Restricted Stock Unit | 1702 | $0.00 | 3,626.0000 | 167,900,000 | 31.94% | 0.00% |
| Feb. 17, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Restricted Stock Unit | 1920 | $0.00 | 5,328.0000 | 167,900,000 | 26.49% | 0.00% |
| Feb. 17, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | F | Common Stock | 929 | $278.38 | 45,911.0000 | 167,900,000 | 1.98% | 0.00% |
| Feb. 17, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Common Stock | 1920 | $0.00 | 46,840.0000 | 167,900,000 | 4.27% | 0.00% |
| Feb. 17, 2023 | Gregory Ginger | EVP, Human Resources | J | Restricted Stock Unit | 1590 | $0.00 | 3,386.0000 | 167,900,000 | 31.95% | 0.00% |
| Feb. 17, 2023 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1792 | $0.00 | 4,976.0000 | 167,900,000 | 26.48% | 0.00% |
| Feb. 17, 2023 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 867 | $278.38 | 9,280.0168 | 167,900,000 | 8.54% | 0.00% |
| Feb. 17, 2023 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1792 | $0.00 | 11,072.0168 | 167,900,000 | 19.31% | 0.00% |
| Feb. 17, 2023 | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 681 | $0.00 | 1,454.0000 | 167,900,000 | 31.90% | 0.00% |
| Feb. 17, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 767 | $0.00 | 2,135.0000 | 167,900,000 | 26.43% | 0.00% |
| Feb. 17, 2023 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 371 | $278.38 | 5,117.0000 | 167,900,000 | 6.76% | 0.00% |
| Feb. 17, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 767 | $0.00 | 5,884.0000 | 167,900,000 | 14.99% | 0.00% |
| Feb. 17, 2023 | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 454 | $0.00 | 968.0000 | 167,900,000 | 31.93% | 0.00% |
| Feb. 17, 2023 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 512 | $0.00 | 1,422.0000 | 167,900,000 | 26.47% | 0.00% |
| Feb. 17, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 238 | $278.38 | 3,331.7483 | 167,900,000 | 6.67% | 0.00% |
| Feb. 17, 2023 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 512 | $0.00 | 3,843.7483 | 167,900,000 | 15.37% | 0.00% |
| Feb. 17, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | J | Restricted Stock Unit | 2271 | $0.00 | 4,836.0000 | 167,900,000 | 31.95% | 0.00% |
| Feb. 17, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 2561 | $0.00 | 7,107.0000 | 167,900,000 | 26.49% | 0.00% |
| Feb. 17, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1310 | $278.38 | 7,586.0000 | 167,900,000 | 14.73% | 0.00% |
| Feb. 17, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 2561 | $0.00 | 10,147.0000 | 167,900,000 | 33.76% | 0.00% |
| Feb. 17, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 426 | $0.00 | 908.0000 | 167,900,000 | 31.93% | 0.00% |
| Feb. 17, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 480 | $0.00 | 1,334.0000 | 167,900,000 | 26.46% | 0.00% |
| Feb. 17, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 233 | $278.38 | 5,099.2903 | 167,900,000 | 4.37% | 0.00% |
| Feb. 17, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 480 | $0.00 | 5,579.2903 | 167,900,000 | 9.41% | 0.00% |
| Feb. 17, 2023 | Singhal Priya | Head of Development | J | Restricted Stock Unit | 408 | $0.00 | 874.0000 | 167,900,000 | 31.83% | 0.00% |
| Feb. 17, 2023 | Singhal Priya | Head of Development | F | Common Stock | 151 | $278.38 | 3,800.3923 | 167,900,000 | 3.82% | 0.00% |
| Feb. 17, 2023 | Singhal Priya | Head of Development | M | Common Stock | 460 | $0.00 | 3,951.3923 | 167,900,000 | 13.18% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 2271 | $0.00 | 6,379.2903 | 167,900,000 | 55.28% | 0.00% |
| Feb. 10, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | F | Common Stock | 1105 | $286.30 | 8,896.0000 | 167,900,000 | 11.05% | 0.00% |
| Feb. 10, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Common Stock | 3256 | $0.00 | 10,001.0000 | 167,900,000 | 48.27% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 278 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 228 | $0.00 | 278.0000 | 167,900,000 | 45.06% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 833 | $0.00 | 1,667.0000 | 167,900,000 | 33.32% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 261 | $286.30 | 3,569.7483 | 167,900,000 | 6.81% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 67 | $286.30 | 3,830.7483 | 167,900,000 | 1.72% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 228 | $0.00 | 3,897.7483 | 167,900,000 | 6.21% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | J | Restricted Stock Unit | 553 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | F | Common Stock | 262 | $286.30 | 3,669.7483 | 167,900,000 | 6.66% | 0.00% |
| Feb. 10, 2023 | Kramer Robin | Chief Accounting Officer | M | Common Stock | 833 | $0.00 | 3,931.7483 | 167,900,000 | 26.88% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 548 | $286.30 | 12,257.0168 | 167,900,000 | 4.28% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 2110 | $286.30 | 10,147.0168 | 167,900,000 | 17.21% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 2158 | $0.00 | 4,317.0000 | 167,900,000 | 33.33% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | M | Restricted Stock Unit | 1132 | $0.00 | 1,384.0000 | 167,900,000 | 44.99% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | J | Restricted Stock Unit | 1384 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 1515 | $0.00 | 6,359.0000 | 167,900,000 | 31.28% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 462 | $286.30 | 5,897.0000 | 167,900,000 | 7.27% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Common Stock | 453 | $0.00 | 6,350.0000 | 167,900,000 | 7.68% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 220 | $286.30 | 6,130.0000 | 167,900,000 | 3.46% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | F | Common Stock | 642 | $286.30 | 5,488.0000 | 167,900,000 | 10.47% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 1515 | $0.00 | 3,030.0000 | 167,900,000 | 33.33% | 0.00% |
| Feb. 10, 2023 | Izzar Rachid | Head of Global Product Strat. | M | Restricted Stock Unit | 453 | $0.00 | 553.0000 | 167,900,000 | 45.03% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | F | Common Stock | 701 | $286.30 | 47,657.0000 | 167,900,000 | 1.45% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Common Stock | 1448 | $0.00 | 48,358.0000 | 167,900,000 | 3.09% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | F | Common Stock | 764 | $286.30 | 46,910.0000 | 167,900,000 | 1.60% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Common Stock | 2575 | $0.00 | 47,674.0000 | 167,900,000 | 5.71% | 0.00% |
| Feb. 10, 2023 | Singhal Priya | Head of Development | M | Restricted Stock Unit | 1211 | $0.00 | 2,424.0000 | 167,900,000 | 33.31% | 0.00% |
| Feb. 10, 2023 | Singhal Priya | Head of Development | F | Common Stock | 372 | $286.30 | 3,491.3923 | 167,900,000 | 9.63% | 0.00% |
| Feb. 10, 2023 | Singhal Priya | Head of Development | M | Common Stock | 1211 | $0.00 | 3,863.3923 | 167,900,000 | 45.66% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | J | Restricted Stock Unit | 416 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 340 | $0.00 | 416.0000 | 167,900,000 | 44.97% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Restricted Stock Unit | 2271 | $0.00 | 4,544.0000 | 167,900,000 | 33.32% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 165 | $286.30 | 5,332.2903 | 167,900,000 | 3.00% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 537 | $286.30 | 5,497.2903 | 167,900,000 | 8.90% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | M | Common Stock | 340 | $0.00 | 6,034.2903 | 167,900,000 | 5.97% | 0.00% |
| Feb. 10, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | F | Common Stock | 685 | $286.30 | 5,694.2903 | 167,900,000 | 10.74% | 0.00% |
| Feb. 10, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | M | Restricted Stock Unit | 3256 | $0.00 | 6,514.0000 | 167,900,000 | 33.33% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 1132 | $0.00 | 12,805.0168 | 167,900,000 | 9.70% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | F | Common Stock | 648 | $286.30 | 11,673.0168 | 167,900,000 | 5.26% | 0.00% |
| Feb. 10, 2023 | Gregory Ginger | EVP, Human Resources | M | Common Stock | 2158 | $0.00 | 12,321.0168 | 167,900,000 | 21.23% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | J | Restricted Stock Unit | 1770 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Restricted Stock Unit | 1448 | $0.00 | 1,770.0000 | 167,900,000 | 45.00% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | M | Restricted Stock Unit | 2575 | $0.00 | 5,150.0000 | 167,900,000 | 33.33% | 0.00% |
| Feb. 10, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | F | Common Stock | 2737 | $286.30 | 44,920.0000 | 167,900,000 | 5.74% | 0.00% |
| Feb. 8, 2023 | Gregory Ginger | EVP, Human Resources | A | Restricted Stock Unit | 4905 | $0.00 | 4,905.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 8, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | A | Restricted Stock Unit | 6570 | $0.00 | 6,570.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | A | Restricted Stock Unit | 6305 | $0.00 | 6,305.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 2365 | $0.00 | 2,365.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Izzar Rachid | Head of Global Product Strat. | A | Restricted Stock Unit | 6130 | $0.00 | 6,130.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 8, 2023 | MCDONNELL MICHAEL R | EVP, Chief Financial Officer | A | Restricted Stock Unit | 7005 | $0.00 | 7,005.0000 | 167,900,000 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Singhal Priya | Head of Development | A | Restricted Stock Unit | 5485 | $0.00 | 5,485.0000 | 167,900,000 | 9999.99% | 0.00% |
| Jan. 25, 2023 | ALEXANDER SUSAN H | EVP Chief Legal Off & Corp Sec | A | Common Stock | 5703 | $0.00 | 45,099.0000 | 167,900,000 | 14.48% | 0.00% |
| June 7, 2022 | Posner Brian S | Director | G | Common Stock | 150 | $0.00 | 8,025.0000 | 170,800,000 | 1.83% | 0.00% |
| Jan. 25, 2023 | Gregory Ginger | EVP, Human Resources | A | Common Stock | 4452 | $0.00 | 10,163.0168 | 167,900,000 | 77.95% | 0.00% |
| Jan. 25, 2023 | Izzar Rachid | Head of Alzheimer's Disease | A | Common Stock | 1783 | $0.00 | 4,844.0000 | 167,900,000 | 58.25% | 0.00% |
| Jan. 25, 2023 | Murphy Nicole | Head of Pharm Ops and Tech | A | Common Stock | 1340 | $0.00 | 4,108.2903 | 167,900,000 | 48.41% | 0.00% |
| Jan. 25, 2023 | Singhal Priya | Head of Development | A | Common Stock | 1123 | $0.00 | 2,652.3923 | 167,900,000 | 73.43% | 0.00% |
| Jan. 25, 2023 | Kramer Robin | Chief Accounting Officer | A | Common Stock | 887 | $0.00 | 3,098.7483 | 167,900,000 | 40.10% | 0.00% |
| Nov. 15, 2022 | SHERWIN STEPHEN A | Director | G | Common Stock | 695 | $0.00 | 17,778.0000 | 170,800,000 | 3.76% | 0.00% |